TickerFacts.

Global Innovative Platforms Inc. (GIPL): R&D Expense

Annual figures by period end, from SEC filings.

$382.8K
Year ended 2025-09-30
$366.8K
Trailing 12 months to 2026-06-30
2024-09-30: $23.4K2025-09-30: $382.8K$382.8K
2024-09-30 R&D Expense (USD) 2025-09-30
Period endedR&D ExpenseChange YoYSource filing
2025-09-30$382.8Kn/m2026-01-13, From 2024-10-01
2024-09-30$23.4Kn/a2026-01-13, From 2023-10-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Global Innovative Platforms Inc. (GIPL)2025-09-30$382.8Kn/m
Baxter International Inc (BAX)2025-12-31$518.00M-12.2%
Becton Dickinson & Co (BDX)2025-09-30$1.26B+6.3%
3M Co (MMM)2024-12-31$700.00M0.0%
Teleflex Inc (TFX)2025-12-31$144.78M+32.8%
West Pharmaceutical Services Inc (WST)2025-12-31$74.30M+7.5%
Stryker Corp (SYK)2025-12-31$1.62B+10.7%
Haemonetics Corp (HAE)2026-03-28$59.77M-4.7%
KORU Medical Systems, Inc. (KRMD)2025-12-31$4.39M-16.6%

Compare GIPL, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗